ARS Pharmaceuticals Inc (NASDAQ:SPRY) currently has a daily average trading volume of 1.05M but it saw 954915 shares traded in last market. With a market cap of 1.16B USD, the company’s current market price of $12.00 came rising about 4.26 while comparing to the previous closing price of $11.51. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.50 and as low as $2.55. In the recent trading on the day, stock has struck highest price mark of $11.36 while lowest mark touched by it was $12.08.
Taking a look at 20-day trading activity of ARS Pharmaceuticals Inc (SPRY) gives us an average price of $12.86, while its current price level is -27.27% below from 52-week high level whereas it is 370.59% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $11.43 while that of 200 days or SMA-200 reads an average of $8.62. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.58% during that period while stretching the period over a month that increases to 7.42%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.52 which implies that the stock is in neutral territory.
Raymond James upgraded its recommendation for the stock as a “Strong Buy” from “Outperform” on August 13, 2024 while assigning a price target range of $18-$22. Leerink Partners issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $19 and $20.
Over the week, SPRY’s stock price is moving 0.59% up while it is 10.60% when we observe its performance for the past one month. Year-to-date it is 118.98% up and over the past year, the stock is showing an upside performance of 60.43%.
Currently, ARS Pharmaceuticals Inc’s total number of outstanding shares is 96.41M. Company’s return on investment (ROI) stands at -20.83% and return on equity (ROE) at -19.34%. Stock’s beta reads 0.92. Stock has a price to book (P/B) ratio of 5.40 while price to sale or P/S ratio amounts to 2326.56. Its return on asset (ROA) is -18.66% on average.
